Anaphylaxis and anaphylactoid reactions are abrupt, often life-threatening episodes, secondary to the liberation of certain chemical mediators, and their effects on target organs. The number of agents known to trigger such reactions is expanding, with the most common fatal reactions secondary to penicillins, iodinated contrast material (ICM), and hymenoptera stings. Limited studies point to upper airway obstruction and circulatory collapse as the causes of death in man. It is felt that the frequency of cardiovascular involvement is not widely appreciated, and that hypotensive patients can be markedly hypovolemic. The primary goals of treatment should be aimed at preventing or reversing complications, and include immediate attention to the airway, cardiac monitoring, and establishment of intravenous access. The cornerstone of pharmacologic therapy is epinephrine. A comprehensive review of the pathophysiology, symptomatology, and treatment is presented.

Download full-text PDF

Source
http://dx.doi.org/10.1016/0736-4679(83)90014-8DOI Listing

Publication Analysis

Top Keywords

anaphylaxis pathophysiology
4
pathophysiology clinical
4
clinical presentations
4
presentations treatment
4
treatment anaphylaxis
4
anaphylaxis anaphylactoid
4
anaphylactoid reactions
4
reactions abrupt
4
abrupt life-threatening
4
life-threatening episodes
4

Similar Publications

Cardiac return assist blanket (CRAB) safely increases central venous pressure.

J Int Med Res

January 2025

Institute for Health Research, the University of Notre Dame Australia, Department of Research, Sir Charles Gairdner Hospital, Nedlands, Australia.

Objective: The cardiac return assist blanket (CRAB) has been designed to increase central venous pressure (CVP) to manage severe hypotension associated with anaphylaxis. This interventional study aimed to identify the relationship between CRAB pressure and CVP. CRAB pressure was also compared with the change in CVP associated with a straight leg raise (SLR), the Trendelenburg position, and 1 L of compound sodium lactate.

View Article and Find Full Text PDF

Immunoglobulin E (IgE)-mediated food allergy.

Allergy Asthma Clin Immunol

December 2024

Division of Allergy, Department of Pediatrics, Dalhousie University, IWK Health Centre, Halifax, NS, Canada.

Food allergy is defined as an adverse immunologic response to a food. Immunoglobulin E (IgE)-mediated reactions to foods are associated with a broad range of signs and symptoms that may involve any of the following body systems: the skin, gastrointestinal tract, respiratory tract, and cardiovascular system. IgE-mediated food allergy is a leading cause of anaphylaxis.

View Article and Find Full Text PDF
Article Synopsis
  • A 44-year-old man experienced a severe allergic reaction after receiving SonoVue during a heart test, leading to chest pain and a heart attack caused by stent thrombosis and coronary vasospasm.
  • Treatment involved mechanical thrombectomy, stent replacement, and careful management to avoid worsening the patient's condition, ultimately resulting in his recovery and discharge with normal heart function.
View Article and Find Full Text PDF

Omalizumab safety concerns.

J Allergy Clin Immunol

January 2025

Division of Allergic Diseases, Mayo Clinic, Rochester, Minn. Electronic address:

IgE and mast cells play key roles in the pathophysiology of allergic diseases. In 2003, omalizumab was the first anti-IgE mAb licensed in the United States when initially US Food and Drug Administration-approved for the treatment of allergic asthma. Since that time, the number of US Food and Drug Administration-approved indications for treatment with omalizumab has grown to include chronic spontaneous urticaria, chronic rhinosinusitis with nasal polyps, and food allergy.

View Article and Find Full Text PDF

Allergenic protein-induced type I hypersensitivity models: a review.

Front Allergy

October 2024

Institute of Translational Medicine, Medical College, Yangzhou University, Yangzhou, China.

Context: Type I hypersensitivity affects approximately one-third of the global population. As the pathophysiology underlying the development of type I hypersensitivity (asthma, food allergy, and anaphylactic shock, etc.) is complex and heterogeneous, animal model studies continue to be the key to identifying novel molecular pathways and providing therapeutic strategies.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!